814857

Gadal Laboratories Inc. — FEI 3008611487

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 23, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
121521 CFR 211.67(b)Written procedures not established/followed
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
136121 CFR 211.100(a)Absence of Written Procedures
1549221 CFR 111.25(a)Procedures - calibrating instruments
1549421 CFR 111.25(c)Procedures - equipment - cleaning, sanitizing
1552521 CFR 111.30(b)Equipment - automated - suitability
1554421 CFR 111.260(d)Batch record - component; unique identifier
1576221 CFR 111.205(a)Master manufacturing record - each batch
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
1586121 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
1604221 CFR 111.503Written procedures - returned dietary supplement
191221 CFR 211.166(a)Written program not followed
194321 CFR 211.180(e)(1)Review of representative number of batches
200821 CFR 211.186(a)Written procedures followed
200921 CFR 211.188Prepared for each batch, include complete information
360321 CFR 211.160(b)Scientifically sound laboratory controls
363221 CFR 211.170(b)Annual visual exams of drug products
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs